Professor Michael G Wyllie
Prof Wyllie, Director and Founder of Global Pharma Consulting, is a graduate of the University of Aberdeen. He has over 30 years of experience in senior management positions in the pharmaceutical industry. While Director at Pfizer he was involved in the discovery, filing of intellectual property, development, regulatory filing and marketing of eight major pharmaceutical products.
Jonathan has 26 years’ experience in both Emerging Companies and Emerging Markets. His core expertise is in equities, covering research, sales and corporate finance, predominantly as Managing Director of Deutsche Bank and Barings in New York.
Oliver de Giorgio-Miller
Chief Operating Officer
Oliver has a wealth of experience in the management and commercial advancement of life science companies. He has worked for over 30 years with several global pharmaceutical and medical device companies.
Mr David Baynes
David was appointed as a non-executive director in September 2010. He is the Chief Executive and co-founder of Fusion IP plc, a company that owns the rights to 100% of university-owned research generated at two of the UK’s leading universities, the University of Sheffield and Cardiff University.
Sir Roger Jones OBE
Sir Roger is a specialist in the economics of pharmaceutical development and a non-executive director. He is a former Chairman of the Welsh Development Agency and a Governor of the BBC and worked for Wellcome Foundation Ltd.